VAERS 2519530
MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U039958
- Staat
- LA
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 30.11.2022
- Impfdatum
- 17.11.2022
- Beginn
- 17.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Symptomtext
No additional AE reported; Customer reported a patient got PROQUAD and VARIVAX today (11/17/2022) instead of MMR II and VARIVAX.; Customer reported a patient got PROQUAD and VARIVAX today (11/17/2022) instead of MMR II and VARIVAX.; This spontaneous report was received from a medical assistant regarding a 12-month-old male patient. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 17-NOV-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) 0.5 ml, product quantity 1, lot #U039958, expiration date: 14-JUN-2023 (also reported as 24-JUN-2023, conflicting information), administered as prophylaxis (strength, and route of administration were not provided); and varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 ml, lot #U039947, expiration date: 16-DEC-2023, administered as prophylaxis (strength, and route of administration were not provided) (Overdose) instead of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), and varicella virus vaccine live (oka/merck) (VARIVAX) (Wrong product administered).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Overdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -